Utilisation rates of treatment intensification for metastatic hormone sensitive prostate cancer (mHSPC) in England, UK

被引：2
|
作者：
Dodkins, J. [1 ]
Cook, A. [1 ]
Nossiter, J. [1 ]
Payne, H. A. [2 ]
Clarke, N. W. [3 ]
van der Meulen, J. [4 ]
Aggarwal, A. [4 ]
机构：
[1] Royal Coll Surgeons England, Clin Effectiveness Unit, London, England
[2] Univ Coll London Hosp NHS Fdn Trust, Dept Oncol, London, England
[3] Christie & Salford Royal NHS Fdn Trusts, Dept Urol, Manchester, Lancs, England
[4] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2740
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1790P
引用
收藏
页码：S967 / S967
页数：1
相关论文
共 50 条
  • [31] ARASENS: A phase 3 trial of darolutamide in males with metastatic hormone-sensitive prostate cancer (mHSPC)
    Tombal, B.
    Saad, F.
    Hussain, M.
    Sternberg, C. N.
    Fizazi, K.
    Crawford, E. D.
    Yamada, K.
    Kappeler, C.
    Kuss, I.
    Smith, M. R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [32] Clinical outcomes in stratification subgroups in the ARASENS study in metastatic hormone-sensitive prostate cancer (mHSPC)
    Parnis, F.
    Tombal, B.
    Hussain, M.
    Saad, F.
    Fizazi, K.
    Sternberg, C. N.
    Crawford, E. D.
    Kopyltsov, E.
    Kalebasty, A. Rezazadeh
    Alekseev, B. Y.
    Montesa Pino, A.
    Ye, D.
    Melo Cruz, F. J. S.
    Tammela, T.
    Suzuki, H.
    Joensuu, H.
    Thiele, S.
    Li, R.
    Kuss, I.
    Smith, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1501 - S1502
  • [33] Evaluating the impact of Via Pathways (VP) on the adoption of changing treatment paradigms in metastatic hormone-sensitive prostate cancer (mHSPC).
    Friedland, David
    Barry, Amanda
    Ellis, Peter G.
    Sweeney, Christopher
    McCutcheon, Stephanie
    Lokay, Kathleen
    Benson, Hans
    Krebs, Melinda
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Transcriptional profiling of metastatic hormone sensitive prostate cancer (mHSPC) and distinct features are associated with clinical outcome
    Jee, B.
    Kang, Y.
    Kim, G.
    Kang, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1499 - S1500
  • [35] Evaluation of Trends in Treatment of Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Across Canada During the COVID-19 Pandemic
    Stecca, Carlos E.
    Jiang, Di Maria
    Veitch, Zachary
    Hotte, Sebastian J.
    Alimohamed, Nimira
    Wood, Lori
    Sridhar, Srikala S.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 273 - 277
  • [36] Apalutamide toxicity and tolerability: A real-world multicentre experience in metastatic hormone-sensitive prostate cancer (MHSPC) in the United Kingdom (UK).
    Ramamurthy, Sindhu
    Elumalai, Thiraviyam
    Pearson, Rachel
    Bolnykh, Iakov
    Muhammad-Afzal, Tehreem
    Olukiran, Gbenro
    Arora, Ananya
    Bradley, Gay
    Taft, Kate
    Myint, Nayan Lin
    Htike, Ei The
    Ince, Will
    Jiang, Xue Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [37] Treatment guideline concordance for patients with metastatic hormone-sensitive prostate cancer (mHSPC) in the United States in IRONMAN, the International Registry for Men with Advanced Prostate Cancer
    McManus, Hannah Dzimitrowicz
    Howard, Lauren
    Crowell, Kerri-Anne
    Hyslop, Terry
    Vinson, Jake
    Rathkopf, Dana E.
    Kantoff, Philip
    Mucci, Lorelei A.
    George, Daniel
    Stopsack, Konrad
    CANCER RESEARCH, 2024, 84 (06)
  • [38] Treatment of primary cancer in metastatic hormone-sensitive prostate cancer
    Lim, Kylie Y. -Y.
    Alberto, Matthew
    Ranasinghe, Weranja
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2023, 17 (04) : 315 - 323
  • [39] The role of chemotherapy in the treatment of hormone sensitive metastatic prostate cancer
    Luis Perez-Gracia, Jose
    Diez Caballero, Fernando
    Gurpide, Alfonso
    de Fata Chillon, Fernando Ramon
    Villacampa, Felipe
    ARCHIVOS ESPANOLES DE UROLOGIA, 2018, 71 (03): : 276 - 280
  • [40] Metastatic hormone sensitive prostate cancer: local treatment strategies
    Walz, Jochen
    Pignot, Geraldine
    Fakhfakh, Sami
    Campagna, Jennifer
    Guerin, Mathilde
    Vicier, Cecile
    Brunelle, Serge
    Salem, Naji
    Gravis, Gwenaelle
    WORLD JOURNAL OF UROLOGY, 2021, 39 (02) : 327 - 337
12345